Amicogen Inc. | Mutual Funds
Mutual Funds that own Amicogen Inc.
Vanguard Total International Stock Index Fund
239,491
1.25%
0
0%
07/31/2018
184,090
0.96%
0
1.82%
09/06/2018
Vanguard Developed Markets Index Fund
95,216
0.5%
0
0%
07/31/2018
Vanguard FTSE All World (ex-US) Small Cap
40,589
0.21%
0
0.02%
07/31/2018
Mirae Asset TIGER Health Care ETF
34,325
0.18%
9,303
0.9%
04/30/2018
Government Pension Fund - Global (The)
33,214
0.17%
33,214
0%
12/31/2017
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
33,200
0.17%
0
0.01%
09/05/2018
Schwab International Small Cap Equity ETF
19,604
0.1%
0
0.03%
09/06/2018
Vanguard Pacific Stock Index Fund
17,228
0.09%
0
0.01%
07/31/2018
SPDR S&P International Small Cap ETF
13,432
0.07%
0
0.06%
09/06/2018
| Address |
64 Dongbu-ro 1259 beon-gil
Jinju SG 52621
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.amicogen.com |
| Updated |
09/14/2018 |
| Amicogen, Inc. engages in the development and marketing of enzyme products and functional food materials. Its products include specialty enzyme for pharmaceutical, food, feed and industrial; new bio-ingredient such as natural health ingredients for food, feed and cosmetics, finished products; and immunological products such as protein A resin, anticancer treatment vaccine based on B cell and mononuclear cell, and POCT immune diagnosis device using innovative C-ECL technology. It also engages in original equipment manufacturing and original development manufacturing of nutraceutical products. |
